Literature DB >> 12626422

The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.

Kevin Mills1, Philippa B Mills, Peter T Clayton, Nasi Mian, Andrew W Johnson, Bryan G Winchester.   

Abstract

Conditions under which the glycosylation capacity of cells is limited provide an opportunity for studying the efficiency of site-specific glycosylation and the role of glycosylation in the maturation of glycoproteins. Congenital disorders of glycosylation type 1 (CDG-I) provide such a system. CDG-I is characterized by underglycosylation of glycoproteins due to defects in the assembly or transfer of the common dolichol-pyrophosphate-linked oligosaccharide precursor of asparagine-linked glycans. Human plasma alpha1-antitrypsin is normally fully glycosylated at three asparagine residues (46, 83, and 247), but un-, mono-, di-, and fully glycosylated forms of alpha1-antitrypsin were detected by 2D PAGE in the plasma from patients with CDG-I. The state of glycosylation of the three asparagine residues was analyzed in all the underglycosylated forms of alpha1-antitrypsin by peptide mass fingerprinting using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. It was found that asparagine 46 was always glycosylated and that asparagine 83 was never glycosylated in the underglycosylated glycoforms of alpha1-antitrypsin. This showed that the asparagine residues are preferentially glycosylated in the order 46>247>83 in the mature underglycosylated forms of alpha1-antitrypsin found in plasma. It is concluded that the nonoccupancy of glycosylation sites is not random under conditions of decreased glycosylation capacity and that the efficiency of glycosylation site occupancy depends on structural features at each site. The implications of this observation for the intracellular transport and sorting of glycoproteins are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12626422     DOI: 10.1093/glycob/cwg026

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  A missense mutation in the bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation.

Authors:  Bo Thomsen; Per Horn; Frank Panitz; Emøke Bendixen; Anette H Petersen; Lars-Erik Holm; Vivi H Nielsen; Jørgen S Agerholm; Jens Arnbjerg; Christian Bendixen
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

2.  Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active.

Authors:  P Perez; J Adriaansen; C M Goldsmith; C Zheng; B J Baum
Journal:  Oral Dis       Date:  2010-12-02       Impact factor: 3.511

3.  Screening for congenital disorders of glycosylation in the first weeks of life.

Authors:  Christian Thiel; Dorothea Meßner-Schmitt; Georg F Hoffmann; Christian Körner
Journal:  J Inherit Metab Dis       Date:  2012-09-19       Impact factor: 4.982

Review 4.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

5.  Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue.

Authors:  Violette Frochaux; Diana Hildebrand; Anja Talke; Michael W Linscheid; Hartmut Schlüter
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

6.  Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells.

Authors:  Aik-Aun Tan; Wai-Mei Phang; Subash C B Gopinath; Onn H Hashim; Lik Voon Kiew; Yeng Chen
Journal:  Biomed Res Int       Date:  2015-06-17       Impact factor: 3.411

Review 7.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.